nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.11	0.146	CbGbCtD
Tofisopam—CYP3A4—Dapsone—systemic lupus erythematosus	0.0959	0.128	CbGbCtD
Tofisopam—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0832	0.111	CbGbCtD
Tofisopam—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0832	0.111	CbGbCtD
Tofisopam—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0714	0.0949	CbGbCtD
Tofisopam—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0704	0.0937	CbGbCtD
Tofisopam—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0667	0.0888	CbGbCtD
Tofisopam—CYP3A4—Prednisone—systemic lupus erythematosus	0.0665	0.0885	CbGbCtD
Tofisopam—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.063	0.0839	CbGbCtD
Tofisopam—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0415	0.0552	CbGbCtD
Tofisopam—PDE3A—blood plasma—systemic lupus erythematosus	0.0206	0.105	CbGeAlD
Tofisopam—PDE10A—nephron tubule—systemic lupus erythematosus	0.0186	0.0955	CbGeAlD
Tofisopam—PDE2A—cortex of kidney—systemic lupus erythematosus	0.0159	0.0817	CbGeAlD
Tofisopam—PDE10A—tendon—systemic lupus erythematosus	0.0132	0.0678	CbGeAlD
Tofisopam—PDE2A—tendon—systemic lupus erythematosus	0.0132	0.0678	CbGeAlD
Tofisopam—CYP3A4—urine—systemic lupus erythematosus	0.0126	0.0647	CbGeAlD
Tofisopam—PDE2A—lung—systemic lupus erythematosus	0.0116	0.0595	CbGeAlD
Tofisopam—PDE10A—lung—systemic lupus erythematosus	0.0116	0.0595	CbGeAlD
Tofisopam—PDE10A—nervous system—systemic lupus erythematosus	0.0107	0.0551	CbGeAlD
Tofisopam—PDE2A—nervous system—systemic lupus erythematosus	0.0107	0.0551	CbGeAlD
Tofisopam—PDE2A—central nervous system—systemic lupus erythematosus	0.0103	0.053	CbGeAlD
Tofisopam—PDE10A—central nervous system—systemic lupus erythematosus	0.0103	0.053	CbGeAlD
Tofisopam—PDE4A—lung—systemic lupus erythematosus	0.00798	0.0409	CbGeAlD
Tofisopam—PDE3A—tendon—systemic lupus erythematosus	0.00752	0.0386	CbGeAlD
Tofisopam—PDE3A—lung—systemic lupus erythematosus	0.0066	0.0338	CbGeAlD
Tofisopam—CYP3A4—blood plasma—systemic lupus erythematosus	0.00659	0.0338	CbGeAlD
Tofisopam—CYP3A4—kidney—systemic lupus erythematosus	0.00299	0.0153	CbGeAlD
Tofisopam—CYP3A4—nervous system—systemic lupus erythematosus	0.00196	0.01	CbGeAlD
Tofisopam—CYP3A4—central nervous system—systemic lupus erythematosus	0.00189	0.00967	CbGeAlD
Tofisopam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000411	0.00769	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ITGAX—systemic lupus erythematosus	0.000378	0.00707	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—F3—systemic lupus erythematosus	0.000372	0.00697	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IFNA1—systemic lupus erythematosus	0.000356	0.00667	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—JAK1—systemic lupus erythematosus	0.000355	0.00665	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000349	0.00654	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000347	0.0065	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CLU—systemic lupus erythematosus	0.000336	0.0063	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL2RA—systemic lupus erythematosus	0.000332	0.00621	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—P2RY12—systemic lupus erythematosus	0.000326	0.0061	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000317	0.00594	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00031	0.00581	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SELE—systemic lupus erythematosus	0.0003	0.00562	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CSK—systemic lupus erythematosus	0.0003	0.00562	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000289	0.00542	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—F2—systemic lupus erythematosus	0.000289	0.00541	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ITGAM—systemic lupus erythematosus	0.000282	0.00528	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000282	0.00528	CbGpPWpGaD
Tofisopam—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000273	0.00512	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—LYN—systemic lupus erythematosus	0.000272	0.0051	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—JAK1—systemic lupus erythematosus	0.000269	0.00504	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SH2B3—systemic lupus erythematosus	0.000267	0.00501	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000263	0.00492	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000255	0.00478	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2RA—systemic lupus erythematosus	0.000251	0.00471	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000247	0.00463	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—systemic lupus erythematosus	0.00024	0.00449	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000236	0.00442	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000235	0.0044	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000234	0.00437	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS3—systemic lupus erythematosus	0.000229	0.00429	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CSK—systemic lupus erythematosus	0.000228	0.00426	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000224	0.0042	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000219	0.00411	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—F2—systemic lupus erythematosus	0.000219	0.0041	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000214	0.004	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000213	0.00398	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000212	0.00396	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IFNA1—systemic lupus erythematosus	0.00021	0.00393	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.00021	0.00392	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000208	0.0039	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000208	0.00389	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—LYN—systemic lupus erythematosus	0.000207	0.00387	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000206	0.00386	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000205	0.00383	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000204	0.00382	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000203	0.0038	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000199	0.00373	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL2—systemic lupus erythematosus	0.000194	0.00364	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000194	0.00362	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000193	0.00362	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000192	0.0036	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00019	0.00356	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—C3—systemic lupus erythematosus	0.000189	0.00353	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000187	0.00351	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000187	0.0035	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000182	0.00342	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—systemic lupus erythematosus	0.000182	0.0034	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000177	0.00332	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—EP300—systemic lupus erythematosus	0.000174	0.00327	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS3—systemic lupus erythematosus	0.000174	0.00325	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CSK—systemic lupus erythematosus	0.000173	0.00323	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00017	0.00319	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000166	0.00312	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—F2—systemic lupus erythematosus	0.000166	0.0031	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000165	0.0031	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—VEGFA—systemic lupus erythematosus	0.000165	0.00309	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000164	0.00308	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000163	0.00306	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000161	0.00302	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000159	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—JAK1—systemic lupus erythematosus	0.000159	0.00297	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000158	0.00295	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000157	0.00295	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—LYN—systemic lupus erythematosus	0.000157	0.00294	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000155	0.00291	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000154	0.00289	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000154	0.00288	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—systemic lupus erythematosus	0.000152	0.00284	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PRL—systemic lupus erythematosus	0.000151	0.00282	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2RA—systemic lupus erythematosus	0.000148	0.00277	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000148	0.00277	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2—systemic lupus erythematosus	0.000147	0.00276	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000146	0.00274	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000144	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—C3—systemic lupus erythematosus	0.000143	0.00268	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000142	0.00267	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000139	0.0026	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000138	0.00259	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000134	0.00251	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000134	0.00251	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000133	0.00249	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—EP300—systemic lupus erythematosus	0.000132	0.00248	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000129	0.00242	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000129	0.00242	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—F2—systemic lupus erythematosus	0.000129	0.00241	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000127	0.00238	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000126	0.00236	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000126	0.00236	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—F2—systemic lupus erythematosus	0.000126	0.00235	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000125	0.00235	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VEGFA—systemic lupus erythematosus	0.000125	0.00235	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000124	0.00232	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000123	0.0023	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000121	0.00226	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—JAK1—systemic lupus erythematosus	0.00012	0.00225	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000118	0.0022	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000117	0.0022	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000117	0.0022	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—systemic lupus erythematosus	0.000115	0.00215	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000114	0.00214	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PRL—systemic lupus erythematosus	0.000114	0.00214	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000114	0.00214	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000114	0.00213	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000112	0.00211	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000112	0.0021	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000112	0.00209	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—C3—systemic lupus erythematosus	0.000111	0.00209	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00011	0.00207	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000107	0.00201	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—systemic lupus erythematosus	0.000107	0.00201	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CSK—systemic lupus erythematosus	0.000105	0.00196	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000104	0.00195	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000103	0.00193	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS3—systemic lupus erythematosus	0.000102	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CSK—systemic lupus erythematosus	0.000102	0.0019	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000102	0.0019	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.0001	0.00188	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—F2—systemic lupus erythematosus	9.79e-05	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.76e-05	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.62e-05	0.0018	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NCF2—systemic lupus erythematosus	9.56e-05	0.00179	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—C3—systemic lupus erythematosus	9.54e-05	0.00179	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.5e-05	0.00178	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LYN—systemic lupus erythematosus	9.5e-05	0.00178	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD80—systemic lupus erythematosus	9.38e-05	0.00176	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.36e-05	0.00175	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.36e-05	0.00175	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.32e-05	0.00174	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2—systemic lupus erythematosus	9.31e-05	0.00174	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NCF2—systemic lupus erythematosus	9.3e-05	0.00174	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—C3—systemic lupus erythematosus	9.28e-05	0.00174	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LYN—systemic lupus erythematosus	9.24e-05	0.00173	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JAK1—systemic lupus erythematosus	9.12e-05	0.00171	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.1e-05	0.0017	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.06e-05	0.0017	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.87e-05	0.00166	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.74e-05	0.00164	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL2—systemic lupus erythematosus	8.72e-05	0.00163	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2—systemic lupus erythematosus	8.68e-05	0.00163	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—C3—systemic lupus erythematosus	8.66e-05	0.00162	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR5—systemic lupus erythematosus	8.65e-05	0.00162	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.63e-05	0.00162	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.52e-05	0.0016	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.5e-05	0.00159	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2—systemic lupus erythematosus	8.46e-05	0.00158	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—C3—systemic lupus erythematosus	8.45e-05	0.00158	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—C3—systemic lupus erythematosus	8.43e-05	0.00158	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—F2—systemic lupus erythematosus	8.38e-05	0.00157	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—F2—systemic lupus erythematosus	8.15e-05	0.00153	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TYK2—systemic lupus erythematosus	7.92e-05	0.00148	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—EP300—systemic lupus erythematosus	7.79e-05	0.00146	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOS3—systemic lupus erythematosus	7.78e-05	0.00146	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.64e-05	0.00143	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—F2—systemic lupus erythematosus	7.61e-05	0.00142	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JUNB—systemic lupus erythematosus	7.5e-05	0.0014	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.43e-05	0.00139	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—F2—systemic lupus erythematosus	7.42e-05	0.00139	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—F2—systemic lupus erythematosus	7.4e-05	0.00139	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VEGFA—systemic lupus erythematosus	7.38e-05	0.00138	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JUNB—systemic lupus erythematosus	7.3e-05	0.00137	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.13e-05	0.00133	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	7.12e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD80—systemic lupus erythematosus	7.11e-05	0.00133	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.93e-05	0.0013	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRL—systemic lupus erythematosus	6.91e-05	0.00129	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.78e-05	0.00127	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—systemic lupus erythematosus	6.77e-05	0.00127	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.74e-05	0.00126	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRL—systemic lupus erythematosus	6.72e-05	0.00126	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL2—systemic lupus erythematosus	6.61e-05	0.00124	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.6e-05	0.00124	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2—systemic lupus erythematosus	6.59e-05	0.00123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—systemic lupus erythematosus	6.56e-05	0.00123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—systemic lupus erythematosus	6.24e-05	0.00117	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.22e-05	0.00116	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.16e-05	0.00115	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TYK2—systemic lupus erythematosus	6e-05	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.99e-05	0.00112	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EP300—systemic lupus erythematosus	5.91e-05	0.00111	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.89e-05	0.0011	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.64e-05	0.00106	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.6e-05	0.00105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JAK1—systemic lupus erythematosus	5.53e-05	0.00104	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.49e-05	0.00103	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JAK1—systemic lupus erythematosus	5.38e-05	0.00101	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR5—systemic lupus erythematosus	5.24e-05	0.000981	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.16e-05	0.000967	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.14e-05	0.000963	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—systemic lupus erythematosus	5.12e-05	0.000959	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—C3—systemic lupus erythematosus	5.12e-05	0.000959	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.1e-05	0.000956	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR5—systemic lupus erythematosus	5.1e-05	0.000954	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.02e-05	0.00094	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—systemic lupus erythematosus	5e-05	0.000935	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.98e-05	0.000933	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—C3—systemic lupus erythematosus	4.98e-05	0.000932	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.97e-05	0.000931	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.73e-05	0.000885	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.71e-05	0.000882	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—F2—systemic lupus erythematosus	4.49e-05	0.000842	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EP300—systemic lupus erythematosus	4.48e-05	0.000839	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—F2—systemic lupus erythematosus	4.37e-05	0.000819	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD80—systemic lupus erythematosus	4.31e-05	0.000807	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.25e-05	0.000795	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD80—systemic lupus erythematosus	4.19e-05	0.000785	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.01e-05	0.00075	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.9e-05	0.00073	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.9e-05	0.00073	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—systemic lupus erythematosus	3.87e-05	0.000726	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.64e-05	0.000681	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.57e-05	0.000669	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.54e-05	0.000663	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.47e-05	0.00065	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.09e-05	0.000579	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—systemic lupus erythematosus	3.03e-05	0.000567	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.01e-05	0.000564	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.01e-05	0.000563	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—systemic lupus erythematosus	2.94e-05	0.000551	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—systemic lupus erythematosus	2.94e-05	0.00055	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.93e-05	0.000549	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.86e-05	0.000536	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.85e-05	0.000534	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.79e-05	0.000522	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.78e-05	0.00052	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EP300—systemic lupus erythematosus	2.72e-05	0.000509	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EP300—systemic lupus erythematosus	2.64e-05	0.000495	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.57e-05	0.000482	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.5e-05	0.000469	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.36e-05	0.000442	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.3e-05	0.00043	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.17e-05	0.000407	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—systemic lupus erythematosus	1.78e-05	0.000333	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—systemic lupus erythematosus	1.73e-05	0.000324	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.22e-05	0.000228	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	7.69e-06	0.000144	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.91e-06	0.000129	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	6.61e-06	0.000124	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	6.05e-06	0.000113	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	5.03e-06	9.42e-05	CbGpPWpGaD
